Generic Name and Formulations:
Vancomycin HCl 3.75g, 7.5g, 15g; pwd for oral soln after reconstitution; grape-flavored.
Indications for FIRVANQ:
C. difficile-associated diarrhea. Enterocolitis due to S. aureus.
Limitations Of use:
Oral vancomycin HCl not effective for treatment of other types of infections.
C. difficile-associated diarrhea: 125mg 4 times a day for 10 days. Enterocolitis: 500mg–2g per day in 3–4 divided doses for 7–10 days.
40mg/kg per day in 3–4 divided doses for 7–10 days; max 2g/day.
Renal insufficiency and/or colitis. Inflammatory bowel disorders. Underlying hearing loss. Monitor hearing, blood, renal function. Consider monitoring vancomycin serum concentrations. Not for endophthalmitis prophylaxis. Elderly. Pregnancy. Nursing mothers.
Monitor with aminoglycosides, other neurotoxic, nephrotoxic, or ototoxic drugs.
Nausea, abdominal pain, hypokalemia; ototoxicity, nephrotoxicity, superinfection.
Kit—1 (w. diluent)
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Prazosin May Be Effective as Treatment for Alcohol Use Disorder
- Text Message Reminders Improve Medication Adherence in Bipolar I Disorder
- Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in Adulthood
- High Suicidality Among Children With ADHD Mediated by Family Functioning, Psychiatry Comorbidities
- Pilot Study Investigates Lithium vs Quetiapine for Bipolar Spectrum Disorder
- How Personalized Hospital Ratings May Drive Patient-Specific Care in the Digital Age